Research Links

BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has formed LifeMap Sciences, Inc., in collaboration with XenneX, Inc. LifeMap Sciences will develop and commercialize a database of the thousands of cell lineages branching from embryonic stem cells, and their molecular markers. LifeMap Sciences...

By Rob Stein, Published: April 6

In the six months since scientists announced they had infused a drug made from human embryonic stem cells into a partially paralyzed patient’s spine, the identity of the recipient has been shrouded in secrecy.

Recently, rumors began circulating in Internet chat rooms that details about the closely guarded...

The Miami Project to Cure Paralysis finds an on-demand laboratory information management system (LIMS) helps to accelerate discovery in its HCS projects.

Traumatic injury to the central nervous system (CNS) usually results in irreversible loss of function. Consequently, individuals with injured spinal cords can be permanently paralyzed. This function loss occurs...

October 21, 2010

As doctors continued treating Rutgers football player Eric LeGrand for the spinal cord injury suffered in Saturday’s football game, there was no word Wednesday from either the school or the hospital as to his condition or prospects for recovery.

But as uncertain as the immediate future may be for LeGrand,...

About the eLegs prototype:

A paraplegic for 18 years, Amanda Boxtel stands from her wheelchair and takes a few tentative steps. She beams as the bionic skeleton she is wearing helps propel her legs forward.“To take my first step … was just astounding … and then I took another step and another one,” she exclaims afterwards...

PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia. The company announced that, after reviewing the safety data from the first six non-ambulatory patients, the trial's Safety Monitoring Board has unanimously approved moving to the next

ATLANTA, Oct. 12, 2010

Embryonic Stem Cell Test on Spinal Cord Injury

First U.S. Study of Stem Cell Drug on Human Paraplegic; Testing Will Help Determine (CBS/AP)  For the first time ever in the U.S., a patient with a spinal cord injury has been injected with human embryonic stem cells.

The hope: that one day this treatment may help the paralyzed walk again.

On Friday at the Shepherd Center, a spinal cord and brain injury rehabilitation..

Ana Radelat from Washington, DC
CNC News | September 29, 2010
Share Ask a question Comment WASHINGTON -- Yesterday's US Court of Appeal's ruling that overturned a lower court injunction against the federal funding of stem cell research is only the latest round of a protracted political battle over that cutting-edge science.

Continuing lawsuit
And even as hundreds of university and private medical research facilities resume their federally-funded stem cell work, a continuing lawsuit..

By Scott Kirsner
Globe Correspondent / September 26, 2010 

 While most people who suffer a traumatic spinal cord injury never recover their normal functioning, Reynolds has written that his company’s medical device will “restore 80 percent of the patient’s normal functioning.’’ In the company’s early experiments with paralyzed primates, Reynolds has said, “100 percent of our monkeys have gotten up and walked in just about three weeks.’’

He told a Boston audience recently that he hopes to begin a small human trial of the device, which is implanted in the spinal ..

September 22, 2010

Enrollment has begun for the first clinical trial to test a therapy developed from human embryonic stem cells.

The trial’s primary aim is to assess the safety of Geron Corp.’s experimental oligodendrocyte progenitor cells, which have been in development for about a decade. They were derived from some of the earliest human embryonic stem cells ever created.